We represented MRI Interventions, Inc. in a $6 million private placement of common stock and warrants in September 2016. Brookline Capital Markets, a division of CIM securities, acted as lead placement agent for the financing transaction.

MRI Interventions, Inc. (OTCQB: MRIC) is a publicly traded company that is building on the imaging power of magnetic resonance imaging, or MRI, to create innovative platforms for performing the next generation of minimally invasive surgical procedures.

As of February 2020, MRI was rebranded as ClearPoint Neuro, Inc. trading on the Nasdaq as CLPT.